Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer"

Félix Blanc-Durand; Elisa Yaniz-Galende; Alba Llop-Guevara; Catherine Genestie; Violeta Serra; Andrea Herencia-Ropero; Christophe Klein; Dominique Berton; Alain Lortholary; Nadine Dohollou; Christophe Desauw; Michel Fabbro; Emmanuelle Malaurie; Nathalie Bonichon-Lamaichhane; Coraline Dubot; Jean Emmanuel Kurtz; Gaëtan de Rauglaudre; Nadia Raban; Annick Chevalier-Place; Gwenael Ferron; Marie-Christine Kaminsky; Claire Kramer; Etienne Rouleau; Alexandra Leary

doi:10.1016/j.ygyno.2023.05.058

Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer"

Gynecol Oncol. 2023 Aug:175:194. doi: 10.1016/j.ygyno.2023.05.058. Epub 2023 Jun 2.

Authors

Félix Blanc-Durand¹, Elisa Yaniz-Galende², Alba Llop-Guevara³, Catherine Genestie⁴, Violeta Serra³, Andrea Herencia-Ropero³, Christophe Klein⁵, Dominique Berton⁶, Alain Lortholary⁷, Nadine Dohollou⁸, Christophe Desauw⁹, Michel Fabbro¹⁰, Emmanuelle Malaurie¹¹, Nathalie Bonichon-Lamaichhane¹², Coraline Dubot¹³, Jean Emmanuel Kurtz¹⁴, Gaëtan de Rauglaudre¹⁵, Nadia Raban¹⁶, Annick Chevalier-Place¹⁷, Gwenael Ferron¹⁸, Marie-Christine Kaminsky¹⁹, Claire Kramer²⁰, Etienne Rouleau²¹, Alexandra Leary²²

Affiliations

¹ Medical Oncology, Gynecology Unit, Gustave Roussy Institute, Villejuif, France.
² INSERM UMR981, Gustave Roussy Institute, Villejuif, France.
³ Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
⁴ Pathology Department, Gustave Roussy Institute, Villejuif, France.
⁵ Center of Cellular Imaging and Cytometry, INSERM UMRS 1138, Cordeliers Research Center, Paris, France.
⁶ Medical Oncology, GINECO & Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
⁷ Medical Oncology, GINECO-Hôpital Privé du Confluent, Nantes, France.
⁸ Medical Oncology, Polyclinique Bordeaux Nord Aquitain, Bordeaux, France.
⁹ Medical Oncology, Centre Hospitalier Universitaire, Lille, France.
¹⁰ Medical Oncology, ICM Val d'Aurelle, Montpellier, France.
¹¹ Medical Oncology, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
¹² Medical Oncology, Clinique Tivoli-Ducos, Bordeaux, France.
¹³ Medical Oncology, GINECO and Institut Curie - Hôpital René Huguenin, Saint-Cloud, France.
¹⁴ Medical Oncology, CHU Stasbourg, Strasbourg, France.
¹⁵ Medical Oncology, GINECO and Institut Sainte- Catherine, Avignon, France.
¹⁶ Medical Oncology, GINECO and CHU La Milétrie, Poitiers, France.
¹⁷ Medical Oncology, Centre Oscar Lambret, Lille, France.
¹⁸ Medical Oncology, GINECO and Institut Claudius Regaud, Toulouse, France.
¹⁹ Medical Oncology, GINECO and Institut de Cancérologie de Lorraine, Vandoeuvre-Les-, Nancy, France.
²⁰ Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
²¹ Cancer Genetics Laboratory, Gustave Roussy Institute, Villejuif, France.
²² Medical Oncology, Gynecology Unit, Gustave Roussy Institute, Villejuif, France; INSERM UMR981, Gustave Roussy Institute, Villejuif, France. Electronic address: alexandra.leary@gustaveroussy.fr.

PMID: 37271667
DOI: 10.1016/j.ygyno.2023.05.058

No abstract available

Publication types

Published Erratum